Synopsis
Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Cellcristin
2. Citomid
3. Farmistin
4. Leurocristine
5. Oncovin
6. Oncovine
7. Onkocristin
8. Pfs, Vincasar
9. Sulfate, Vincristine
10. Vincasar
11. Vincasar Pfs
12. Vincristin Bristol
13. Vincristin Medac
14. Vincristine
15. Vincrisul
16. Vintec
1. 2068-78-2
2. Kyocristine
3. Vincristine Sulphate
4. Vincrisul
5. Leurocristine Sulfate
6. Oncovin
7. Onkovin
8. Marqibo
9. 22-oxovincaleukoblastine Sulfate
10. Vcr Sulfate
11. Rel-vincristine Sulfate
12. Nsc 67574
13. Lilly 37231
14. Nsc67574
15. Nsc-67574
16. Leurocristine, Sulfate (1:1) (salt)
17. Alkaloid Extracted From Vinca Rosea Linn
18. Novopharm
19. Chebi:79401
20. 1217704-93-2
21. Mls002702994
22. Lilly-37231
23. Vincristini Sulfas
24. Oncovin (lilly)
25. Vincasar (tn)
26. Marqibo (tn)
27. Oncovin (tn)
28. Vincrex (tn)
29. Vincristine, Sulfate
30. Leurocristine, Sulfate
31. Vincristine Sulphate Salt
32. Vincristine Sulfate Liposome
33. Schembl3710
34. Leurocristine Sulfate (1:1)
35. Chembl501867
36. Dtxsid8044331
37. Vincristine Sulfate (jp17/usp)
38. Hms3414l13
39. Hms3678l11
40. Mfcd08706469
41. Akos015895862
42. V0129
43. Lcr
44. Vcr
45. D02197
46. 068v782
47. A936684
48. Methyl (3ar,3a1r,4r,5s,5ar,10br)-4-acetoxy-3a-ethyl-9-((3s,5s,7s,9s)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2h-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,3a1,4,5,5a,6,11,12-octahydro-1h-indolizino[8,1-cd]carbazole-5-carboxylate Sulfate
Molecular Weight | 923.0 g/mol |
---|---|
Molecular Formula | C46H58N4O14S |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 10 |
Exact Mass | 922.36702371 g/mol |
Monoisotopic Mass | 922.36702371 g/mol |
Topological Polar Surface Area | 254 Ų |
Heavy Atom Count | 65 |
Formal Charge | 0 |
Complexity | 1830 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Marqibo kit |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable, liposomal |
Route | Intravenous |
Strength | 5mg/5ml (1mg/ml) |
Market Status | Prescription |
Company | Talon Therap |
2 of 4 | |
---|---|
Drug Name | Vincristine sulfate pfs |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml |
Market Status | Prescription |
Company | Hospira; Teva Pharms Usa |
3 of 4 | |
---|---|
Drug Name | Marqibo kit |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable, liposomal |
Route | Intravenous |
Strength | 5mg/5ml (1mg/ml) |
Market Status | Prescription |
Company | Talon Therap |
4 of 4 | |
---|---|
Drug Name | Vincristine sulfate pfs |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml |
Market Status | Prescription |
Company | Hospira; Teva Pharms Usa |
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Tubulin Modulators
Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Vincristine Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vincristine Sulfate, including repackagers and relabelers. The FDA regulates Vincristine Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vincristine Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vincristine Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vincristine Sulfate supplier is an individual or a company that provides Vincristine Sulfate active pharmaceutical ingredient (API) or Vincristine Sulfate finished formulations upon request. The Vincristine Sulfate suppliers may include Vincristine Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Vincristine Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vincristine Sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of Vincristine Sulfate active pharmaceutical ingredient (API) in detail. Different forms of Vincristine Sulfate DMFs exist exist since differing nations have different regulations, such as Vincristine Sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vincristine Sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. Vincristine Sulfate USDMF includes data on Vincristine Sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vincristine Sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vincristine Sulfate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Vincristine Sulfate Drug Master File in Japan (Vincristine Sulfate JDMF) empowers Vincristine Sulfate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Vincristine Sulfate JDMF during the approval evaluation for pharmaceutical products. At the time of Vincristine Sulfate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Vincristine Sulfate suppliers with JDMF on PharmaCompass.
A Vincristine Sulfate CEP of the European Pharmacopoeia monograph is often referred to as a Vincristine Sulfate Certificate of Suitability (COS). The purpose of a Vincristine Sulfate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vincristine Sulfate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vincristine Sulfate to their clients by showing that a Vincristine Sulfate CEP has been issued for it. The manufacturer submits a Vincristine Sulfate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vincristine Sulfate CEP holder for the record. Additionally, the data presented in the Vincristine Sulfate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vincristine Sulfate DMF.
A Vincristine Sulfate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vincristine Sulfate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Vincristine Sulfate suppliers with CEP (COS) on PharmaCompass.
A Vincristine Sulfate written confirmation (Vincristine Sulfate WC) is an official document issued by a regulatory agency to a Vincristine Sulfate manufacturer, verifying that the manufacturing facility of a Vincristine Sulfate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vincristine Sulfate APIs or Vincristine Sulfate finished pharmaceutical products to another nation, regulatory agencies frequently require a Vincristine Sulfate WC (written confirmation) as part of the regulatory process.
click here to find a list of Vincristine Sulfate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vincristine Sulfate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vincristine Sulfate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vincristine Sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vincristine Sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vincristine Sulfate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vincristine Sulfate suppliers with NDC on PharmaCompass.
Vincristine Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vincristine Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vincristine Sulfate GMP manufacturer or Vincristine Sulfate GMP API supplier for your needs.
A Vincristine Sulfate CoA (Certificate of Analysis) is a formal document that attests to Vincristine Sulfate's compliance with Vincristine Sulfate specifications and serves as a tool for batch-level quality control.
Vincristine Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Vincristine Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vincristine Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Vincristine Sulfate EP), Vincristine Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vincristine Sulfate USP).
LOOKING FOR A SUPPLIER?